FNY Investment Advisers’s Elevation Oncology ELEV Stock Holding History

FNY Investment Advisers’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,000	Closed	-$3K	–	1302
2025 Q2	$3K	Buy	+10,000	New	+$3.34K	﹤0.01%	796

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

FNY Investment Advisers's ELEV Position: Q3 2025 in Review

FNY Investment Advisers sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 10,000 shares — an estimated $3K sold.

FNY Investment Advisers first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $3K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

FNY Investment Advisers reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
FNY Investment Advisers sold 10,000 Elevation Oncology shares in Q3 2025, an estimated $3K.
FNY Investment Advisers first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
FNY Investment Advisers's Elevation Oncology position peaked at $3K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.